Kimura et al. (2007) Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand ...

From GlycoMotif
Revision as of 13:12, 31 March 2021 by Edwardsnj (talk | contribs) (Created page with "{{Publication |authors=Kimura N, Ohmori K, Miyazaki K, Izawa M, Matsuzaki Y, Yasuda Y, Takematsu H, Kozutsumi Y, Moriyama A, Kannagi R |citedby=Cummings_(2009)_The_repertoire_...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Kimura N, Ohmori K, Miyazaki K, Izawa M, Matsuzaki Y, Yasuda Y, Takematsu H, Kozutsumi Y, Moriyama A, Kannagi R. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J. Biol. Chem. 2007 282(44):32200-7. doi:10.1074/jbc.M702341200. PMID: 17728258.

Cited By

Motifs

Accession Name(s) Aglycon Reducing-End? Alignment
GGM.000026
2,6-sialyl-Sulfo-LN, 6-sialyl-6-sulfo LN 		R false Nonreducing-End
Retrieved from "https://glycomotif.glyomics.org/glycomotif/index.php?title=Kimura_et_al._(2007)_Human_B-lymphocytes_express_alpha2-6-sialylated_6-sulfo-N-acetyllactosamine_serving_as_a_preferred_ligand_...&oldid=1969"